Mahmud Tareq Hassan Khan
Mahmud Tareq Hassan Khan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Arjumand Ather
The Norwegian Structural Biology Centre (NorStruct), University of Tromso, Tromso 9037, Norway
1 shared publication- Balladka Kunhanna Sarojini
Department of Industrial Chemistry Mangalore University Mangalagangothri India
1 shared publication - Carlo Mischiati
Department of Neurosciences and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy
1 shared publication Chenna Govindaraju Darshan Raj
P.A. College of Engineering, Nadupadavu
1 shared publication- Claudio Tabolacci
Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy
1 shared publication - Fabio Casciano
Department of Environmental and Prevention Sciences and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy
1 shared publication
Latest Publications
- Open Access
- 6 February 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (4) , 1644
Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib
Among the phenolic acids tested on the K562 cell line, a model of chronic myeloid leukemia (CML), caffeic acid (CA) was biologically active on sensitive and imatinib (IM)-resistant cells at micro-molar concentration, either in terms of reduction of cell proliferation or triggering of apoptosis. The CA treatment provoked mitochondrial membrane depolarization, genomic DNA fragmentation and phosphatidylserine exposure, hallmarks of apoptosis. Cell cycle analysis following the treatment with comparable cytotoxic concentrations of IM or CA showed marked differences in the distribution profiles. The reduction of cell proliferation by CA administration was associated with increased expression of two cell cycle repressor genes, CDKN1A and CHES1, while IM at a cytotoxic concentration increased the CHES1 but not the CDKN1A expression. In addition, CA treatment affected the proliferation and triggered the apoptosis in IM-resistant cells. Taken together, these data suggested that CA induced the anti-proliferative effect and triggered apoptosis of CML cells by a different mechanism than IM. Finally, the combined administration of IM and CA at suboptimal concentrations evidenced a synergy of action in determining the anti-proliferative effect and triggering apoptosis. The ability of CA to potentiate the anti-leukemic effect of IM highlighted the nutraceutical potential of CA in CML.
- 6 February 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (4) , 1644
Open AccessCaffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib
Among the phenolic acids tested on the K562 cell line, a model of chronic myeloid leukemia (CML), caffeic acid (CA) was biologically active on sensitive and imatinib (IM)-resistant cells at micro-molar concentration, either in terms of reduction of cell proliferation or triggering of apoptosis. The CA treatment provoked mitochondrial membrane depolarization, genomic DNA fragmentation and phosphatidylserine exposure, hallmarks of apoptosis. Cell cycle analysis following the treatment with comparable cytotoxic concentrations of IM or CA showed marked differences in the distribution profiles. The reduction of cell proliferation by CA administration was associated with increased expression of two cell cycle repressor genes, CDKN1A and CHES1, while IM at a cytotoxic concentration increased the CHES1 but not the CDKN1A expression. In addition, CA treatment affected the proliferation and triggered the apoptosis in IM-resistant cells. Taken together, these data suggested that CA induced the anti-proliferative effect and triggered apoptosis of CML cells by a different mechanism than IM. Finally, the combined administration of IM and CA at suboptimal concentrations evidenced a synergy of action in determining the anti-proliferative effect and triggering apoptosis. The ability of CA to potentiate the anti-leukemic effect of IM highlighted the nutraceutical potential of CA in CML.
- 27 June 2013
- Published by Springer Nature
- p. 157-165
Natural Products as Potential Resources for Antifungal Substances: A Survey
- 27 June 2013
- Published by Springer Nature
- p. 157-165
Natural Products as Potential Resources for Antifungal Substances: A Survey
- Open Access
- 1 February 2013
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 8 (2) , 186-194
Evaluation of Verbascum species and harpagoside in models of acute and chronic inflammation
Verbascum species are widely used in folk medicine because of their broad range of biological activities. Harpagoside, an iridoid glycoside isolated from some Verbascum plants is known for its anti-inflammatory properties. In the present study, the effect of five extracts of Verbascum species and harpagosides were evaluated in mouse models of acute and chronic inflammation. The results demonstrate that Verbascum phoeniceum extract strongly inhibits COX-1 (60.2% inhibition vs PMA-stimulated cells) and COX-2 (44.8% inhibition) expression stimulated peritoneal macrophages resulting in reduced paw swelling in carrageenan-induced oedema (55.5% inhibition vs PBS-treated mice). Harpagoside ameliorated the development of zymosaninduced arthritis and reduced pathological changes in joints as shown by the decreased histological score for cell infiltration in synovial cavity (3.5±0.2 in vs 2.0±0.16), cartilage loss (2.5±0.3 vs 1.8±0.5) and bone resorption (2.4±0.2 vs 1.8±0.4). Molecular docking simulations of harpagoside suggest that it may function with increased specific affinity towards COX-1 than COX-2. The potential of harpagoside to be applied as an effective agent for treating joint-related disorders is discussed.
- 1 February 2013
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 8 (2) , 186-194
Open AccessEvaluation of Verbascum species and harpagoside in models of acute and chronic inflammation
Verbascum species are widely used in folk medicine because of their broad range of biological activities. Harpagoside, an iridoid glycoside isolated from some Verbascum plants is known for its anti-inflammatory properties. In the present study, the effect of five extracts of Verbascum species and harpagosides were evaluated in mouse models of acute and chronic inflammation. The results demonstrate that Verbascum phoeniceum extract strongly inhibits COX-1 (60.2% inhibition vs PMA-stimulated cells) and COX-2 (44.8% inhibition) expression stimulated peritoneal macrophages resulting in reduced paw swelling in carrageenan-induced oedema (55.5% inhibition vs PBS-treated mice). Harpagoside ameliorated the development of zymosaninduced arthritis and reduced pathological changes in joints as shown by the decreased histological score for cell infiltration in synovial cavity (3.5±0.2 in vs 2.0±0.16), cartilage loss (2.5±0.3 vs 1.8±0.5) and bone resorption (2.4±0.2 vs 1.8±0.4). Molecular docking simulations of harpagoside suggest that it may function with increased specific affinity towards COX-1 than COX-2. The potential of harpagoside to be applied as an effective agent for treating joint-related disorders is discussed.
- 6 October 2012
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 22 (5) , 2430-2436
In vivo antidiabetic activity and in silico studies on adenosine monophosphate-activated protein kinase (AMPK) of (2E,5E)-2,5-bis(4-hydroxy-3-methoxybenzylidene) cyclopentanone
- 6 October 2012
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 22 (5) , 2430-2436
In vivo antidiabetic activity and in silico studies on adenosine monophosphate-activated protein kinase (AMPK) of (2E,5E)-2,5-bis(4-hydroxy-3-methoxybenzylidene) cyclopentanone
- 13 April 2007
- Published by Wiley in QSAR & Combinatorial Science
- Vol. 26 (4) , 469-487
Atom‐Based 2D Quadratic Indices in Drug Discovery of Novel Tyrosinase Inhibitors: Results of In Silico Studies Supported by Experimental Results
Herein we present results of QSAR studies of tyrosinase inhibitors employing one of the atom‐based TOMOCOMD‐CARDD (acronym of TOpological MOlecular COMputer Design‐Computer Aided “Rational” Drug Design) descriptors, molecular quadratic indices, and Linear Discriminant Analysis (LDA) as pattern recognition method. In this way, a database of 246 organic chemicals, reported as tyrosinase inhibitors having great structural variability, was analyzed and presented as a helpful tool, not only for theoretical chemists but also for other researchers in this area. In total, 12 LDA‐based QSAR models were obtained, the first six with the non‐stochastic total and local quadratic indices and the six remaining models with the stochastic molecular descriptors. The best two models for the non‐stochastic and stochastic molecular descriptors, showed an appropriate overall accuracy (92.68 and 89.10%, respectively) and a high Matthews correlation coefficient (C of 0.85 and of 0.84, correspondingly) when applied to the training set. External validation series were also used to validate the obtained models; the 91.67% (C=0.82) and 90.00% (C=0.78), were correctly classified, respectively. In order to show the possibilities of the present approach for the ligand‐based virtual screening of tyrosinase inhibitors, the developed models were used afterwards in a simulation of a virtual search for tyrosinase inhibitors. For instance, more than 93% (93.33%) and 96% (96.66%) of the screened chemicals were correctly classified by the two best LDA‐based QSAR models developed with non‐stochastic and stochastic quadratic indices, respectively. Finally, the combination of the obtained models permitted the selection/identification of new diterpenoidal alkaloid leads as tyrosinase inhibitors. The found activity is supported by observed inhibitory effects on mushroom tyrosinase enzyme, even comparable with some reference tyrosinase inhibitors. These results support a role for TOMOCOMD‐CARDD descriptors in the biosilico discovery of novel tyrosinase inhibitors from large databases of chemical structures (virtual or “in silico”), which may be used to prevent or treat pigmentation disorders.
- 13 April 2007
- Published by Wiley in QSAR & Combinatorial Science
- Vol. 26 (4) , 469-487
Atom‐Based 2D Quadratic Indices in Drug Discovery of Novel Tyrosinase Inhibitors: Results of In Silico Studies Supported by Experimental Results
Herein we present results of QSAR studies of tyrosinase inhibitors employing one of the atom‐based TOMOCOMD‐CARDD (acronym of TOpological MOlecular COMputer Design‐Computer Aided “Rational” Drug Design) descriptors, molecular quadratic indices, and Linear Discriminant Analysis (LDA) as pattern recognition method. In this way, a database of 246 organic chemicals, reported as tyrosinase inhibitors having great structural variability, was analyzed and presented as a helpful tool, not only for theoretical chemists but also for other researchers in this area. In total, 12 LDA‐based QSAR models were obtained, the first six with the non‐stochastic total and local quadratic indices and the six remaining models with the stochastic molecular descriptors. The best two models for the non‐stochastic and stochastic molecular descriptors, showed an appropriate overall accuracy (92.68 and 89.10%, respectively) and a high Matthews correlation coefficient (C of 0.85 and of 0.84, correspondingly) when applied to the training set. External validation series were also used to validate the obtained models; the 91.67% (C=0.82) and 90.00% (C=0.78), were correctly classified, respectively. In order to show the possibilities of the present approach for the ligand‐based virtual screening of tyrosinase inhibitors, the developed models were used afterwards in a simulation of a virtual search for tyrosinase inhibitors. For instance, more than 93% (93.33%) and 96% (96.66%) of the screened chemicals were correctly classified by the two best LDA‐based QSAR models developed with non‐stochastic and stochastic quadratic indices, respectively. Finally, the combination of the obtained models permitted the selection/identification of new diterpenoidal alkaloid leads as tyrosinase inhibitors. The found activity is supported by observed inhibitory effects on mushroom tyrosinase enzyme, even comparable with some reference tyrosinase inhibitors. These results support a role for TOMOCOMD‐CARDD descriptors in the biosilico discovery of novel tyrosinase inhibitors from large databases of chemical structures (virtual or “in silico”), which may be used to prevent or treat pigmentation disorders.